Patient_ID.x;Description_2.x;NA;geo_accession;title;status;submission_date;last_update_date;type;channel_count;source_name_ch1;organism_ch1;characteristics_ch1;characteristics_ch1.1;characteristics_ch1.2;characteristics_ch1.3;molecule_ch1;extract_protocol_ch1;label_ch1;label_protocol_ch1;taxid_ch1;hyb_protocol;scan_protocol;description;data_processing;platform_id;contact_name;contact_email;contact_institute;contact_address;contact_city;contact_state;contact_zip/postal_code;contact_country;supplementary_file;data_row_count;disease state:ch1;genotype:ch1;location:ch1;treatment:ch1;Patient_ID.y;Description_2.y;B_cell;CAF;Endo_cell;Macrophage;NK;Other_cells;T_cell
Patient;1;Pre untreated;GSM1220412;Patient 1 Pre untreated;Public on Feb 19 2014;Aug 30 2013;Feb 19 2014;RNA;1;Melanoma tumour;Homo sapiens;genotype: BRAF V600E;disease state: melanoma;location: brain;treatment: none;total RNA;RNA was extracted with Trizol reagent, followed by clean-up and DNase I treatment with QIAGEN RNeasy mini kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.;biotin;Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays;9606;Standard Illumina hybridization protocol;Standard Illumina scanning protocol;Patient 1 Pre untreated;The data were normalised using with cubic spline using the Illumina GenomeStudio v2011.1;GPL10558;Gulietta,,Pupo;gulietta.pupo@sydney.edu.au;University of Sydney;Darcy Road;Westmead;NSW;2145;Australia;NONE;47323;melanoma;BRAF V600E;brain;none;1;Pre untreated;0,275376374;0;0,000743165;0,045610319;0,021659351;0;0,65661079
Patient;1;Prog Treated with dabrafenib;GSM1220413;Patient 1 Prog Treated with dabrafenib;Public on Feb 19 2014;Aug 30 2013;Feb 19 2014;RNA;1;Melanoma tumour;Homo sapiens;genotype: BRAF V600E;disease state: melanoma;location: subcutaneous;treatment: dabrafenib;total RNA;RNA was extracted with Trizol reagent, followed by clean-up and DNase I treatment with QIAGEN RNeasy mini kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.;biotin;Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays;9606;Standard Illumina hybridization protocol;Standard Illumina scanning protocol;Patient 1 Prog Treated with dabrafenib;The data were normalised using with cubic spline using the Illumina GenomeStudio v2011.1;GPL10558;Gulietta,,Pupo;gulietta.pupo@sydney.edu.au;University of Sydney;Darcy Road;Westmead;NSW;2145;Australia;NONE;47323;melanoma;BRAF V600E;subcutaneous;dabrafenib;1;Prog Treated with dabrafenib;0,102308131;0,032125765;0,061095534;0;0,024244364;0,285460524;0,494765683
Patient;2;Pre untreated;GSM1220414;Patient 2 Pre untreated;Public on Feb 19 2014;Aug 30 2013;Feb 19 2014;RNA;1;Melanoma tumour;Homo sapiens;genotype: BRAF V600E;disease state: melanoma;location: subcutaneous;treatment: none;total RNA;RNA was extracted with Trizol reagent, followed by clean-up and DNase I treatment with QIAGEN RNeasy mini kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.;biotin;Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays;9606;Standard Illumina hybridization protocol;Standard Illumina scanning protocol;Patient 2 Pre untreated;The data were normalised using with cubic spline using the Illumina GenomeStudio v2011.1;GPL10558;Gulietta,,Pupo;gulietta.pupo@sydney.edu.au;University of Sydney;Darcy Road;Westmead;NSW;2145;Australia;NONE;47323;melanoma;BRAF V600E;subcutaneous;none;2;Pre untreated;0,301613516;0,006213191;0,004456826;0,002653334;0,060415999;0;0,624647134
Patient;2;Prog Treated with dabrafenib;GSM1220415;Patient 2 Prog Treated with dabrafenib;Public on Feb 19 2014;Aug 30 2013;Feb 19 2014;RNA;1;Melanoma tumour;Homo sapiens;genotype: BRAF V600E;disease state: melanoma;location: subcutaneous;treatment: dabrafenib;total RNA;RNA was extracted with Trizol reagent, followed by clean-up and DNase I treatment with QIAGEN RNeasy mini kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.;biotin;Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays;9606;Standard Illumina hybridization protocol;Standard Illumina scanning protocol;Patient 2 Prog Treated with dabrafenib;The data were normalised using with cubic spline using the Illumina GenomeStudio v2011.1;GPL10558;Gulietta,,Pupo;gulietta.pupo@sydney.edu.au;University of Sydney;Darcy Road;Westmead;NSW;2145;Australia;NONE;47323;melanoma;BRAF V600E;subcutaneous;dabrafenib;2;Prog Treated with dabrafenib;0,252210028;0;0;0,116608655;0,044574714;0;0,586606603
Patient;3;Pre untreated;GSM1220416;Patient 3 Pre untreated;Public on Feb 19 2014;Aug 30 2013;Feb 19 2014;RNA;1;Melanoma tumour;Homo sapiens;genotype: BRAF V600K;disease state: melanoma;location: subcutaneous;treatment: none;total RNA;RNA was extracted with Trizol reagent, followed by clean-up and DNase I treatment with QIAGEN RNeasy mini kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.;biotin;Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays;9606;Standard Illumina hybridization protocol;Standard Illumina scanning protocol;Patient 3 Pre untreated;The data were normalised using with cubic spline using the Illumina GenomeStudio v2011.1;GPL10558;Gulietta,,Pupo;gulietta.pupo@sydney.edu.au;University of Sydney;Darcy Road;Westmead;NSW;2145;Australia;NONE;47323;melanoma;BRAF V600K;subcutaneous;none;3;Pre untreated;0,108720295;0;0,019944622;0;0;0,368736173;0,502598911
Patient;3;Prog 1 Treated with dabrafenib;GSM1220417;Patient 3 Prog 1 Treated with dabrafenib;Public on Feb 19 2014;Aug 30 2013;Feb 19 2014;RNA;1;Melanoma tumour;Homo sapiens;genotype: BRAF V600K;disease state: melanoma;location: subcutaneous;treatment: dabrafenib;total RNA;RNA was extracted with Trizol reagent, followed by clean-up and DNase I treatment with QIAGEN RNeasy mini kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.;biotin;Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays;9606;Standard Illumina hybridization protocol;Standard Illumina scanning protocol;Patient 3 Prog 1 Treated with dabrafenib;The data were normalised using with cubic spline using the Illumina GenomeStudio v2011.1;GPL10558;Gulietta,,Pupo;gulietta.pupo@sydney.edu.au;University of Sydney;Darcy Road;Westmead;NSW;2145;Australia;NONE;47323;melanoma;BRAF V600K;subcutaneous;dabrafenib;3;Prog 1 Treated with dabrafenib;0,123006736;0,01182853;0,030660215;0;0;0,311650169;0,522854349
Patient;3;Prog 2 Treated with dabrafenib;GSM1220418;Patient 3 Prog 2 Treated with dabrafenib;Public on Feb 19 2014;Aug 30 2013;Feb 19 2014;RNA;1;Melanoma tumour;Homo sapiens;genotype: BRAF V600K;disease state: melanoma;location: subcutaneous;treatment: dabrafenib;total RNA;RNA was extracted with Trizol reagent, followed by clean-up and DNase I treatment with QIAGEN RNeasy mini kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.;biotin;Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays;9606;Standard Illumina hybridization protocol;Standard Illumina scanning protocol;Patient 3 Prog 2 Treated with dabrafenib;The data were normalised using with cubic spline using the Illumina GenomeStudio v2011.1;GPL10558;Gulietta,,Pupo;gulietta.pupo@sydney.edu.au;University of Sydney;Darcy Road;Westmead;NSW;2145;Australia;NONE;47323;melanoma;BRAF V600K;subcutaneous;dabrafenib;3;Prog 2 Treated with dabrafenib;0,099011661;0,033746623;0,025619917;0,016876113;0;0,366036439;0,458709247
Patient;4;Pre untreated;GSM1220419;Patient 4 Pre untreated;Public on Feb 19 2014;Aug 30 2013;Feb 19 2014;RNA;1;Melanoma tumour;Homo sapiens;genotype: BRAF V600K;disease state: melanoma;location: brain;treatment: none;total RNA;RNA was extracted with Trizol reagent, followed by clean-up and DNase I treatment with QIAGEN RNeasy mini kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.;biotin;Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays;9606;Standard Illumina hybridization protocol;Standard Illumina scanning protocol;Patient 4 Pre untreated;The data were normalised using with cubic spline using the Illumina GenomeStudio v2011.1;GPL10558;Gulietta,,Pupo;gulietta.pupo@sydney.edu.au;University of Sydney;Darcy Road;Westmead;NSW;2145;Australia;NONE;47323;melanoma;BRAF V600K;brain;none;4;Pre untreated;0,077653363;0,010800425;0,039084563;0;0,00031385;0,340981538;0,531166261
Patient;4;Prog Treated with dabrafenib;GSM1220420;Patient 4 Prog Treated with dabrafenib;Public on Feb 19 2014;Aug 30 2013;Feb 19 2014;RNA;1;Melanoma tumour;Homo sapiens;genotype: BRAF V600K;disease state: melanoma;location: bowel;treatment: dabrafenib;total RNA;RNA was extracted with Trizol reagent, followed by clean-up and DNase I treatment with QIAGEN RNeasy mini kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.;biotin;Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays;9606;Standard Illumina hybridization protocol;Standard Illumina scanning protocol;Patient 4 Prog Treated with dabrafenib;The data were normalised using with cubic spline using the Illumina GenomeStudio v2011.1;GPL10558;Gulietta,,Pupo;gulietta.pupo@sydney.edu.au;University of Sydney;Darcy Road;Westmead;NSW;2145;Australia;NONE;47323;melanoma;BRAF V600K;bowel;dabrafenib;4;Prog Treated with dabrafenib;0,081695367;0,00614746;0,055935852;0;0,001164329;0,347409624;0,507647367
Patient;5;Pre untreated;GSM1220421;Patient 5 Pre untreated;Public on Feb 19 2014;Aug 30 2013;Feb 19 2014;RNA;1;Melanoma tumour;Homo sapiens;genotype: BRAF V600K;disease state: melanoma;location: subcutaneous;treatment: none;total RNA;RNA was extracted with Trizol reagent, followed by clean-up and DNase I treatment with QIAGEN RNeasy mini kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.;biotin;Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays;9606;Standard Illumina hybridization protocol;Standard Illumina scanning protocol;Patient 5 Pre untreated;The data were normalised using with cubic spline using the Illumina GenomeStudio v2011.1;GPL10558;Gulietta,,Pupo;gulietta.pupo@sydney.edu.au;University of Sydney;Darcy Road;Westmead;NSW;2145;Australia;NONE;47323;melanoma;BRAF V600K;subcutaneous;none;5;Pre untreated;0,100894941;0;0,001750954;0;0;0,341136234;0,556217871
Patient;5;EDT treated with dabrafenib;GSM1220422;Patient 5 EDT treated with dabrafenib;Public on Feb 19 2014;Aug 30 2013;Feb 19 2014;RNA;1;Melanoma tumour;Homo sapiens;genotype: BRAF V600K;disease state: melanoma;location: subcutaneous;treatment: dabrafenib;total RNA;RNA was extracted with Trizol reagent, followed by clean-up and DNase I treatment with QIAGEN RNeasy mini kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.;biotin;Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays;9606;Standard Illumina hybridization protocol;Standard Illumina scanning protocol;Patient 5 EDT treated with dabrafenib;The data were normalised using with cubic spline using the Illumina GenomeStudio v2011.1;GPL10558;Gulietta,,Pupo;gulietta.pupo@sydney.edu.au;University of Sydney;Darcy Road;Westmead;NSW;2145;Australia;NONE;47323;melanoma;BRAF V600K;subcutaneous;dabrafenib;5;EDT treated with dabrafenib;0,171355068;0;0;0,090797621;0,007885481;0;0,72996183
Patient;5;Prog Treated with dabrafenib;GSM1220423;Patient 5 Prog Treated with dabrafenib;Public on Feb 19 2014;Aug 30 2013;Feb 19 2014;RNA;1;Melanoma tumour;Homo sapiens;genotype: BRAF V600K;disease state: melanoma;location: subcutaneous;treatment: dabrafenib;total RNA;RNA was extracted with Trizol reagent, followed by clean-up and DNase I treatment with QIAGEN RNeasy mini kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.;biotin;Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays;9606;Standard Illumina hybridization protocol;Standard Illumina scanning protocol;Patient 5 Prog Treated with dabrafenib;The data were normalised using with cubic spline using the Illumina GenomeStudio v2011.1;GPL10558;Gulietta,,Pupo;gulietta.pupo@sydney.edu.au;University of Sydney;Darcy Road;Westmead;NSW;2145;Australia;NONE;47323;melanoma;BRAF V600K;subcutaneous;dabrafenib;5;Prog Treated with dabrafenib;0,063712419;0,024443231;0,014481013;0;0;0,363676404;0,533686933
Patient;7;Pre untreated;GSM1220424;Patient 7 Pre untreated;Public on Feb 19 2014;Aug 30 2013;Feb 19 2014;RNA;1;Melanoma tumour;Homo sapiens;genotype: BRAF V600E;disease state: melanoma;location: subcutaneous;treatment: none;total RNA;RNA was extracted with Trizol reagent, followed by clean-up and DNase I treatment with QIAGEN RNeasy mini kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.;biotin;Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays;9606;Standard Illumina hybridization protocol;Standard Illumina scanning protocol;Patient 7 Pre untreated;The data were normalised using with cubic spline using the Illumina GenomeStudio v2011.1;GPL10558;Gulietta,,Pupo;gulietta.pupo@sydney.edu.au;University of Sydney;Darcy Road;Westmead;NSW;2145;Australia;NONE;47323;melanoma;BRAF V600E;subcutaneous;none;7;Pre untreated;0,047475046;0;0;0,131207021;0,018355146;0;0,802962787
Patient;7;Pre untreated (replicate);GSM1220425;Patient 7 Pre untreated (replicate);Public on Feb 19 2014;Aug 30 2013;Feb 19 2014;RNA;1;Melanoma tumour;Homo sapiens;genotype: BRAF V600E;disease state: melanoma;location: subcutaneous;treatment: none;total RNA;RNA was extracted with Trizol reagent, followed by clean-up and DNase I treatment with QIAGEN RNeasy mini kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.;biotin;Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays;9606;Standard Illumina hybridization protocol;Standard Illumina scanning protocol;Patient 7 Pre untreated (replicate);The data were normalised using with cubic spline using the Illumina GenomeStudio v2011.1;GPL10558;Gulietta,,Pupo;gulietta.pupo@sydney.edu.au;University of Sydney;Darcy Road;Westmead;NSW;2145;Australia;NONE;47323;melanoma;BRAF V600E;subcutaneous;none;7;Pre untreated (replicate);0,063222124;0;0;0,124073557;0,023169714;0;0,789534606
Patient;7;Prog Treated with dabrafenib;GSM1220426;Patient 7 Prog Treated with dabrafenib;Public on Feb 19 2014;Aug 30 2013;Feb 19 2014;RNA;1;Melanoma tumour;Homo sapiens;genotype: BRAF V600E;disease state: melanoma;location: lymph node;treatment: dabrafenib;total RNA;RNA was extracted with Trizol reagent, followed by clean-up and DNase I treatment with QIAGEN RNeasy mini kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.;biotin;Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays;9606;Standard Illumina hybridization protocol;Standard Illumina scanning protocol;Patient 7 Prog Treated with dabrafenib;The data were normalised using with cubic spline using the Illumina GenomeStudio v2011.1;GPL10558;Gulietta,,Pupo;gulietta.pupo@sydney.edu.au;University of Sydney;Darcy Road;Westmead;NSW;2145;Australia;NONE;47323;melanoma;BRAF V600E;lymph node;dabrafenib;7;Prog Treated with dabrafenib;0,177631619;0;0;0,207362333;0,063436355;0,00653991;0,545029783
Patient;8;Pre untreated;GSM1220427;Patient 8 Pre untreated;Public on Feb 19 2014;Aug 30 2013;Feb 19 2014;RNA;1;Melanoma tumour;Homo sapiens;genotype: BRAF V600E;disease state: melanoma;location: subcutaneous;treatment: none;total RNA;RNA was extracted with Trizol reagent, followed by clean-up and DNase I treatment with QIAGEN RNeasy mini kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.;biotin;Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays;9606;Standard Illumina hybridization protocol;Standard Illumina scanning protocol;Patient 8 Pre untreated;The data were normalised using with cubic spline using the Illumina GenomeStudio v2011.1;GPL10558;Gulietta,,Pupo;gulietta.pupo@sydney.edu.au;University of Sydney;Darcy Road;Westmead;NSW;2145;Australia;NONE;47323;melanoma;BRAF V600E;subcutaneous;none;8;Pre untreated;0,116643981;0,097656889;0,053958436;0,068377864;0,055156494;0,017006343;0,591199993
Patient;8;Pre untreated (replicate);GSM1220428;Patient 8 Pre untreated (replicate);Public on Feb 19 2014;Aug 30 2013;Feb 19 2014;RNA;1;Melanoma tumour;Homo sapiens;genotype: BRAF V600E;disease state: melanoma;location: subcutaneous;treatment: none;total RNA;RNA was extracted with Trizol reagent, followed by clean-up and DNase I treatment with QIAGEN RNeasy mini kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.;biotin;Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays;9606;Standard Illumina hybridization protocol;Standard Illumina scanning protocol;Patient 8 Pre untreated (replicate);The data were normalised using with cubic spline using the Illumina GenomeStudio v2011.1;GPL10558;Gulietta,,Pupo;gulietta.pupo@sydney.edu.au;University of Sydney;Darcy Road;Westmead;NSW;2145;Australia;NONE;47323;melanoma;BRAF V600E;subcutaneous;none;8;Pre untreated (replicate);0,141741228;0,12431229;0,035518084;0;0,02701652;0,09208132;0,579330558
Patient;8;Prog 1 Treated with dabrafenib;GSM1220429;Patient 8 Prog 1 Treated with dabrafenib;Public on Feb 19 2014;Aug 30 2013;Feb 19 2014;RNA;1;Melanoma tumour;Homo sapiens;genotype: BRAF V600E;disease state: melanoma;location: subcutaneous;treatment: dabrafenib;total RNA;RNA was extracted with Trizol reagent, followed by clean-up and DNase I treatment with QIAGEN RNeasy mini kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.;biotin;Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays;9606;Standard Illumina hybridization protocol;Standard Illumina scanning protocol;Patient 8 Prog 1 Treated with dabrafenib;The data were normalised using with cubic spline using the Illumina GenomeStudio v2011.1;GPL10558;Gulietta,,Pupo;gulietta.pupo@sydney.edu.au;University of Sydney;Darcy Road;Westmead;NSW;2145;Australia;NONE;47323;melanoma;BRAF V600E;subcutaneous;dabrafenib;8;Prog 1 Treated with dabrafenib;0,221460719;0,043757403;0;0,067365239;0;0;0,66741664
Patient;8;Prog 2 Treated with dabrafenib;GSM1220430;Patient 8 Prog 2 Treated with dabrafenib;Public on Feb 19 2014;Aug 30 2013;Feb 19 2014;RNA;1;Melanoma tumour;Homo sapiens;genotype: BRAF V600E;disease state: melanoma;location: subcutaneous;treatment: dabrafenib;total RNA;RNA was extracted with Trizol reagent, followed by clean-up and DNase I treatment with QIAGEN RNeasy mini kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.;biotin;Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays;9606;Standard Illumina hybridization protocol;Standard Illumina scanning protocol;Patient 8 Prog 2 Treated with dabrafenib;The data were normalised using with cubic spline using the Illumina GenomeStudio v2011.1;GPL10558;Gulietta,,Pupo;gulietta.pupo@sydney.edu.au;University of Sydney;Darcy Road;Westmead;NSW;2145;Australia;NONE;47323;melanoma;BRAF V600E;subcutaneous;dabrafenib;8;Prog 2 Treated with dabrafenib;0,144578224;0,031956932;0,040772981;0;0;0,214709993;0,56798187
Patient;9;Pre untreated;GSM1220431;Patient 9 Pre untreated;Public on Feb 19 2014;Aug 30 2013;Feb 19 2014;RNA;1;Melanoma tumour;Homo sapiens;genotype: BRAF V600E;disease state: melanoma;location: subcutaneous;treatment: none;total RNA;RNA was extracted with Trizol reagent, followed by clean-up and DNase I treatment with QIAGEN RNeasy mini kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.;biotin;Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays;9606;Standard Illumina hybridization protocol;Standard Illumina scanning protocol;Patient 9 Pre untreated;The data were normalised using with cubic spline using the Illumina GenomeStudio v2011.1;GPL10558;Gulietta,,Pupo;gulietta.pupo@sydney.edu.au;University of Sydney;Darcy Road;Westmead;NSW;2145;Australia;NONE;47323;melanoma;BRAF V600E;subcutaneous;none;9;Pre untreated;0,19873997;0;0;0,07746336;0,040410779;0;0,683385891
Patient;9;Prog Treated with dabrafenib;GSM1220432;Patient 9 Prog Treated with dabrafenib;Public on Feb 19 2014;Aug 30 2013;Feb 19 2014;RNA;1;Melanoma tumour;Homo sapiens;genotype: BRAF V600E;disease state: melanoma;location: subcutaneous;treatment: dabrafenib;total RNA;RNA was extracted with Trizol reagent, followed by clean-up and DNase I treatment with QIAGEN RNeasy mini kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.;biotin;Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays;9606;Standard Illumina hybridization protocol;Standard Illumina scanning protocol;Patient 9 Prog Treated with dabrafenib;The data were normalised using with cubic spline using the Illumina GenomeStudio v2011.1;GPL10558;Gulietta,,Pupo;gulietta.pupo@sydney.edu.au;University of Sydney;Darcy Road;Westmead;NSW;2145;Australia;NONE;47323;melanoma;BRAF V600E;subcutaneous;dabrafenib;9;Prog Treated with dabrafenib;0,191524724;0;0;0,12437937;0,033297538;0;0,650798369
Patient;10;Pre untreated;GSM1220433;Patient 10 Pre untreated;Public on Feb 19 2014;Aug 30 2013;Feb 19 2014;RNA;1;Melanoma tumour;Homo sapiens;genotype: BRAF V600E;disease state: melanoma;location: subcutaneous;treatment: none;total RNA;RNA was extracted with Trizol reagent, followed by clean-up and DNase I treatment with QIAGEN RNeasy mini kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.;biotin;Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays;9606;Standard Illumina hybridization protocol;Standard Illumina scanning protocol;Patient 10 Pre untreated;The data were normalised using with cubic spline using the Illumina GenomeStudio v2011.1;GPL10558;Gulietta,,Pupo;gulietta.pupo@sydney.edu.au;University of Sydney;Darcy Road;Westmead;NSW;2145;Australia;NONE;47323;melanoma;BRAF V600E;subcutaneous;none;10;Pre untreated;0,167378173;0;0;0,072425545;0,056151602;0;0,70404468
Patient;10;Pre untreated (replicate);GSM1220434;Patient 10 Pre untreated (replicate);Public on Feb 19 2014;Aug 30 2013;Feb 19 2014;RNA;1;Melanoma tumour;Homo sapiens;genotype: BRAF V600E;disease state: melanoma;location: subcutaneous;treatment: none;total RNA;RNA was extracted with Trizol reagent, followed by clean-up and DNase I treatment with QIAGEN RNeasy mini kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.;biotin;Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays;9606;Standard Illumina hybridization protocol;Standard Illumina scanning protocol;Patient 10 Pre untreated (replicate);The data were normalised using with cubic spline using the Illumina GenomeStudio v2011.1;GPL10558;Gulietta,,Pupo;gulietta.pupo@sydney.edu.au;University of Sydney;Darcy Road;Westmead;NSW;2145;Australia;NONE;47323;melanoma;BRAF V600E;subcutaneous;none;10;Pre untreated (replicate);0,181137188;0;0;0,06710826;0,054136727;0;0,697617825
Patient;10;EDT Treated with dabrafenib;GSM1220435;Patient 10 EDT Treated with dabrafenib;Public on Feb 19 2014;Aug 30 2013;Feb 19 2014;RNA;1;Melanoma tumour;Homo sapiens;genotype: BRAF V600E;disease state: melanoma;location: subcutaneous;treatment: dabrafenib;total RNA;RNA was extracted with Trizol reagent, followed by clean-up and DNase I treatment with QIAGEN RNeasy mini kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.;biotin;Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays;9606;Standard Illumina hybridization protocol;Standard Illumina scanning protocol;Patient 10 EDT Treated with dabrafenib;The data were normalised using with cubic spline using the Illumina GenomeStudio v2011.1;GPL10558;Gulietta,,Pupo;gulietta.pupo@sydney.edu.au;University of Sydney;Darcy Road;Westmead;NSW;2145;Australia;NONE;47323;melanoma;BRAF V600E;subcutaneous;dabrafenib;10;EDT Treated with dabrafenib;0,251778628;0;0;0,059700214;0,000111249;0,023695685;0,664714224
Patient;10;Prog 1 Treated with dabrafenib;GSM1220436;Patient 10 Prog 1 Treated with dabrafenib;Public on Feb 19 2014;Aug 30 2013;Feb 19 2014;RNA;1;Melanoma tumour;Homo sapiens;genotype: BRAF V600E;disease state: melanoma;location: subcutaneous;treatment: dabrafenib;total RNA;RNA was extracted with Trizol reagent, followed by clean-up and DNase I treatment with QIAGEN RNeasy mini kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.;biotin;Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays;9606;Standard Illumina hybridization protocol;Standard Illumina scanning protocol;Patient 10 Prog 1 Treated with dabrafenib;The data were normalised using with cubic spline using the Illumina GenomeStudio v2011.1;GPL10558;Gulietta,,Pupo;gulietta.pupo@sydney.edu.au;University of Sydney;Darcy Road;Westmead;NSW;2145;Australia;NONE;47323;melanoma;BRAF V600E;subcutaneous;dabrafenib;10;Prog 1 Treated with dabrafenib;0,195160315;0,044001262;0,030890652;0;0;0,151657149;0,578290622
Patient;10;Prog 2 Treated with dabrafenib;GSM1220437;Patient 10 Prog 2 Treated with dabrafenib;Public on Feb 19 2014;Aug 30 2013;Feb 19 2014;RNA;1;Melanoma tumour;Homo sapiens;genotype: BRAF V600E;disease state: melanoma;location: subcutaneous;treatment: dabrafenib;total RNA;RNA was extracted with Trizol reagent, followed by clean-up and DNase I treatment with QIAGEN RNeasy mini kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.;biotin;Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays;9606;Standard Illumina hybridization protocol;Standard Illumina scanning protocol;Patient 10 Prog 2 Treated with dabrafenib;The data were normalised using with cubic spline using the Illumina GenomeStudio v2011.1;GPL10558;Gulietta,,Pupo;gulietta.pupo@sydney.edu.au;University of Sydney;Darcy Road;Westmead;NSW;2145;Australia;NONE;47323;melanoma;BRAF V600E;subcutaneous;dabrafenib;10;Prog 2 Treated with dabrafenib;0,087059592;0,024215348;0,03727429;0;0,003985273;0,290278471;0,557187026
Patient;11;Pre untreated;GSM1220438;Patient 11 Pre untreated;Public on Feb 19 2014;Aug 30 2013;Feb 19 2014;RNA;1;Melanoma tumour;Homo sapiens;genotype: BRAF V600K;disease state: melanoma;location: lymph node;treatment: none;total RNA;RNA was extracted with Trizol reagent, followed by clean-up and DNase I treatment with QIAGEN RNeasy mini kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.;biotin;Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays;9606;Standard Illumina hybridization protocol;Standard Illumina scanning protocol;Patient 11 Pre untreated;The data were normalised using with cubic spline using the Illumina GenomeStudio v2011.1;GPL10558;Gulietta,,Pupo;gulietta.pupo@sydney.edu.au;University of Sydney;Darcy Road;Westmead;NSW;2145;Australia;NONE;47323;melanoma;BRAF V600K;lymph node;none;11;Pre untreated;0,064976843;0,016573284;0,012334951;0;0;0,407698817;0,498416105
Patient;11;Pre untreated (replicate);GSM1220439;Patient 11 Pre untreated (replicate);Public on Feb 19 2014;Aug 30 2013;Feb 19 2014;RNA;1;Melanoma tumour;Homo sapiens;genotype: BRAF V600K;disease state: melanoma;location: lymph node;treatment: none;total RNA;RNA was extracted with Trizol reagent, followed by clean-up and DNase I treatment with QIAGEN RNeasy mini kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.;biotin;Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays;9606;Standard Illumina hybridization protocol;Standard Illumina scanning protocol;Patient 11 Pre untreated (replicate);The data were normalised using with cubic spline using the Illumina GenomeStudio v2011.1;GPL10558;Gulietta,,Pupo;gulietta.pupo@sydney.edu.au;University of Sydney;Darcy Road;Westmead;NSW;2145;Australia;NONE;47323;melanoma;BRAF V600K;lymph node;none;11;Pre untreated (replicate);0,064547931;0,006284134;0,001249043;0;0;0,457781828;0,470137065
Patient;11;Prog 1 Treated with dabrafenib;GSM1220440;Patient 11 Prog 1 Treated with dabrafenib;Public on Feb 19 2014;Aug 30 2013;Feb 19 2014;RNA;1;Melanoma tumour;Homo sapiens;genotype: BRAF V600K;disease state: melanoma;location: subcutaneous;treatment: dabrafenib;total RNA;RNA was extracted with Trizol reagent, followed by clean-up and DNase I treatment with QIAGEN RNeasy mini kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.;biotin;Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays;9606;Standard Illumina hybridization protocol;Standard Illumina scanning protocol;Patient 11 Prog 1 Treated with dabrafenib;The data were normalised using with cubic spline using the Illumina GenomeStudio v2011.1;GPL10558;Gulietta,,Pupo;gulietta.pupo@sydney.edu.au;University of Sydney;Darcy Road;Westmead;NSW;2145;Australia;NONE;47323;melanoma;BRAF V600K;subcutaneous;dabrafenib;11;Prog 1 Treated with dabrafenib;0,286623953;0;0,000842531;0,077904383;0,001154004;0;0,633475129
Patient;11;Prog 2 Treated with dabrafenib;GSM1220441;Patient 11 Prog 2 Treated with dabrafenib;Public on Feb 19 2014;Aug 30 2013;Feb 19 2014;RNA;1;Melanoma tumour;Homo sapiens;genotype: BRAF V600K;disease state: melanoma;location: brain;treatment: dabrafenib;total RNA;RNA was extracted with Trizol reagent, followed by clean-up and DNase I treatment with QIAGEN RNeasy mini kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.;biotin;Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays;9606;Standard Illumina hybridization protocol;Standard Illumina scanning protocol;Patient 11 Prog 2 Treated with dabrafenib;The data were normalised using with cubic spline using the Illumina GenomeStudio v2011.1;GPL10558;Gulietta,,Pupo;gulietta.pupo@sydney.edu.au;University of Sydney;Darcy Road;Westmead;NSW;2145;Australia;NONE;47323;melanoma;BRAF V600K;brain;dabrafenib;11;Prog 2 Treated with dabrafenib;0,081498846;0,025846914;0,023705113;0;0;0,328121411;0,540827715
Patient;11;Prog 1 Treated with dabrafenib (replicate);GSM1220442;Patient 11 Prog 1 Treated with dabrafenib (replicate);Public on Feb 19 2014;Aug 30 2013;Feb 19 2014;RNA;1;Melanoma tumour;Homo sapiens;genotype: BRAF V600K;disease state: melanoma;location: subcutaneous;treatment: dabrafenib;total RNA;RNA was extracted with Trizol reagent, followed by clean-up and DNase I treatment with QIAGEN RNeasy mini kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.;biotin;Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays;9606;Standard Illumina hybridization protocol;Standard Illumina scanning protocol;Patient 11 Prog 1 Treated with dabrafenib (replicate);The data were normalised using with cubic spline using the Illumina GenomeStudio v2011.1;GPL10558;Gulietta,,Pupo;gulietta.pupo@sydney.edu.au;University of Sydney;Darcy Road;Westmead;NSW;2145;Australia;NONE;47323;melanoma;BRAF V600K;subcutaneous;dabrafenib;11;Prog 1 Treated with dabrafenib (replicate);0,315492388;0;0;0,065383164;0;0;0,619124448
Patient;11;Prog 2 Treated with dabrafenib (replicate);GSM1220443;Patient 11 Prog 2 Treated with dabrafenib (replicate);Public on Feb 19 2014;Aug 30 2013;Feb 19 2014;RNA;1;Melanoma tumour;Homo sapiens;genotype: BRAF V600K;disease state: melanoma;location: brain;treatment: dabrafenib;total RNA;RNA was extracted with Trizol reagent, followed by clean-up and DNase I treatment with QIAGEN RNeasy mini kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.;biotin;Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays;9606;Standard Illumina hybridization protocol;Standard Illumina scanning protocol;Patient 11 Prog 2 Treated with dabrafenib (replicate);The data were normalised using with cubic spline using the Illumina GenomeStudio v2011.1;GPL10558;Gulietta,,Pupo;gulietta.pupo@sydney.edu.au;University of Sydney;Darcy Road;Westmead;NSW;2145;Australia;NONE;47323;melanoma;BRAF V600K;brain;dabrafenib;11;Prog 2 Treated with dabrafenib (replicate);0,075871169;0,017907294;0,012236384;0;0,002498928;0,375728026;0,515758199
Patient;12;Pre untreated;GSM1220444;Patient 12 Pre untreated;Public on Feb 19 2014;Aug 30 2013;Feb 19 2014;RNA;1;Melanoma tumour;Homo sapiens;genotype: BRAF V600K;disease state: melanoma;location: lymph node;treatment: none;total RNA;RNA was extracted with Trizol reagent, followed by clean-up and DNase I treatment with QIAGEN RNeasy mini kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.;biotin;Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays;9606;Standard Illumina hybridization protocol;Standard Illumina scanning protocol;Patient 12 Pre untreated;The data were normalised using with cubic spline using the Illumina GenomeStudio v2011.1;GPL10558;Gulietta,,Pupo;gulietta.pupo@sydney.edu.au;University of Sydney;Darcy Road;Westmead;NSW;2145;Australia;NONE;47323;melanoma;BRAF V600K;lymph node;none;12;Pre untreated;0,281901981;0,018975849;0;0,024284807;0;0,04543194;0,629405423
Patient;12;Prog Treated with dabrafenib;GSM1220445;Patient 12 Prog Treated with dabrafenib;Public on Feb 19 2014;Aug 30 2013;Feb 19 2014;RNA;1;Melanoma tumour;Homo sapiens;genotype: BRAF V600K;disease state: melanoma;location: subcutaneous;treatment: dabrafenib;total RNA;RNA was extracted with Trizol reagent, followed by clean-up and DNase I treatment with QIAGEN RNeasy mini kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.;biotin;Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays;9606;Standard Illumina hybridization protocol;Standard Illumina scanning protocol;Patient 12 Prog Treated with dabrafenib;The data were normalised using with cubic spline using the Illumina GenomeStudio v2011.1;GPL10558;Gulietta,,Pupo;gulietta.pupo@sydney.edu.au;University of Sydney;Darcy Road;Westmead;NSW;2145;Australia;NONE;47323;melanoma;BRAF V600K;subcutaneous;dabrafenib;12;Prog Treated with dabrafenib;0,186133572;0,002158384;0,024144347;0,158901287;0,007013709;0,02385606;0,597792642
Patient;13;Pre untreated;GSM1220446;Patient 13 Pre untreated;Public on Feb 19 2014;Aug 30 2013;Feb 19 2014;RNA;1;Melanoma tumour;Homo sapiens;genotype: BRAF V600E;disease state: melanoma;location: subcutaneous;treatment: none;total RNA;RNA was extracted with Trizol reagent, followed by clean-up and DNase I treatment with QIAGEN RNeasy mini kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.;biotin;Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays;9606;Standard Illumina hybridization protocol;Standard Illumina scanning protocol;Patient 13 Pre untreated;The data were normalised using with cubic spline using the Illumina GenomeStudio v2011.1;GPL10558;Gulietta,,Pupo;gulietta.pupo@sydney.edu.au;University of Sydney;Darcy Road;Westmead;NSW;2145;Australia;NONE;47323;melanoma;BRAF V600E;subcutaneous;none;13;Pre untreated;0,127136774;0,024844967;0,040098968;0;0;0,306602019;0,501317272
Patient;13;Pre untreated (replicate);GSM1220447;Patient 13 Pre untreated (replicate);Public on Feb 19 2014;Aug 30 2013;Feb 19 2014;RNA;1;Melanoma tumour;Homo sapiens;genotype: BRAF V600E;disease state: melanoma;location: subcutaneous;treatment: none;total RNA;RNA was extracted with Trizol reagent, followed by clean-up and DNase I treatment with QIAGEN RNeasy mini kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.;biotin;Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays;9606;Standard Illumina hybridization protocol;Standard Illumina scanning protocol;Patient 13 Pre untreated (replicate);The data were normalised using with cubic spline using the Illumina GenomeStudio v2011.1;GPL10558;Gulietta,,Pupo;gulietta.pupo@sydney.edu.au;University of Sydney;Darcy Road;Westmead;NSW;2145;Australia;NONE;47323;melanoma;BRAF V600E;subcutaneous;none;13;Pre untreated (replicate);0,096852167;0,020725265;0,03882981;0;0;0,350852764;0,492739994
Patient;13;Prog Treated with dabrafenib;GSM1220448;Patient 13 Prog Treated with dabrafenib;Public on Feb 19 2014;Aug 30 2013;Feb 19 2014;RNA;1;Melanoma tumour;Homo sapiens;genotype: BRAF V600E;disease state: melanoma;location: subcutaneous;treatment: dabrafenib;total RNA;RNA was extracted with Trizol reagent, followed by clean-up and DNase I treatment with QIAGEN RNeasy mini kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.;biotin;Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays;9606;Standard Illumina hybridization protocol;Standard Illumina scanning protocol;Patient 13 Prog Treated with dabrafenib;The data were normalised using with cubic spline using the Illumina GenomeStudio v2011.1;GPL10558;Gulietta,,Pupo;gulietta.pupo@sydney.edu.au;University of Sydney;Darcy Road;Westmead;NSW;2145;Australia;NONE;47323;melanoma;BRAF V600E;subcutaneous;dabrafenib;13;Prog Treated with dabrafenib;0,316723532;0;0;0,008921552;0;0;0,674354916
Patient;14;Pre untreated;GSM1220449;Patient 14 Pre untreated;Public on Feb 19 2014;Aug 30 2013;Feb 19 2014;RNA;1;Melanoma tumour;Homo sapiens;genotype: BRAF V600K;disease state: melanoma;location: brain;treatment: none;total RNA;RNA was extracted with Trizol reagent, followed by clean-up and DNase I treatment with QIAGEN RNeasy mini kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.;biotin;Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays;9606;Standard Illumina hybridization protocol;Standard Illumina scanning protocol;Patient 14 Pre untreated;The data were normalised using with cubic spline using the Illumina GenomeStudio v2011.1;GPL10558;Gulietta,,Pupo;gulietta.pupo@sydney.edu.au;University of Sydney;Darcy Road;Westmead;NSW;2145;Australia;NONE;47323;melanoma;BRAF V600K;brain;none;14;Pre untreated;0,099823144;0,032701354;0,074571856;0;0,019307618;0,095331081;0,678264947
Patient;14;Prog Treated with dabrafenib;GSM1220450;Patient 14 Prog Treated with dabrafenib;Public on Feb 19 2014;Aug 30 2013;Feb 19 2014;RNA;1;Melanoma tumour;Homo sapiens;genotype: BRAF V600K;disease state: melanoma;location: subcutaneous;treatment: dabrafenib;total RNA;RNA was extracted with Trizol reagent, followed by clean-up and DNase I treatment with QIAGEN RNeasy mini kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.;biotin;Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays;9606;Standard Illumina hybridization protocol;Standard Illumina scanning protocol;Patient 14 Prog Treated with dabrafenib;The data were normalised using with cubic spline using the Illumina GenomeStudio v2011.1;GPL10558;Gulietta,,Pupo;gulietta.pupo@sydney.edu.au;University of Sydney;Darcy Road;Westmead;NSW;2145;Australia;NONE;47323;melanoma;BRAF V600K;subcutaneous;dabrafenib;14;Prog Treated with dabrafenib;0,172287625;0,017775833;0,024203089;0,047256745;0,014810482;0,101488625;0,6221776
Patient;17;Pre untreated;GSM1220451;Patient 17 Pre untreated;Public on Feb 19 2014;Aug 30 2013;Feb 19 2014;RNA;1;Melanoma tumour;Homo sapiens;genotype: BRAF V600E;disease state: melanoma;location: brain;treatment: none;total RNA;RNA was extracted with Trizol reagent, followed by clean-up and DNase I treatment with QIAGEN RNeasy mini kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.;biotin;Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays;9606;Standard Illumina hybridization protocol;Standard Illumina scanning protocol;Patient 17 Pre untreated;The data were normalised using with cubic spline using the Illumina GenomeStudio v2011.1;GPL10558;Gulietta,,Pupo;gulietta.pupo@sydney.edu.au;University of Sydney;Darcy Road;Westmead;NSW;2145;Australia;NONE;47323;melanoma;BRAF V600E;brain;none;17;Pre untreated;0,049408179;0,042432133;0,058766887;0,036665047;0,027658197;0,167230101;0,617839456
Patient;17;Prog Treated with dabrafenib;GSM1220452;Patient 17 Prog Treated with dabrafenib;Public on Feb 19 2014;Aug 30 2013;Feb 19 2014;RNA;1;Melanoma tumour;Homo sapiens;genotype: BRAF V600E;disease state: melanoma;location: lung;treatment: dabrafenib;total RNA;RNA was extracted with Trizol reagent, followed by clean-up and DNase I treatment with QIAGEN RNeasy mini kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.;biotin;Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays;9606;Standard Illumina hybridization protocol;Standard Illumina scanning protocol;Patient 17 Prog Treated with dabrafenib;The data were normalised using with cubic spline using the Illumina GenomeStudio v2011.1;GPL10558;Gulietta,,Pupo;gulietta.pupo@sydney.edu.au;University of Sydney;Darcy Road;Westmead;NSW;2145;Australia;NONE;47323;melanoma;BRAF V600E;lung;dabrafenib;17;Prog Treated with dabrafenib;0,117457082;0;0;0,063500726;0,048866403;0;0,770175789
Patient;18;Pre untreated;GSM1220453;Patient 18 Pre untreated;Public on Feb 19 2014;Aug 30 2013;Feb 19 2014;RNA;1;Melanoma tumour;Homo sapiens;genotype: BRAF V600E;disease state: melanoma;location: subcutaneous;treatment: none;total RNA;RNA was extracted with Trizol reagent, followed by clean-up and DNase I treatment with QIAGEN RNeasy mini kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.;biotin;Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays;9606;Standard Illumina hybridization protocol;Standard Illumina scanning protocol;Patient 18 Pre untreated;The data were normalised using with cubic spline using the Illumina GenomeStudio v2011.1;GPL10558;Gulietta,,Pupo;gulietta.pupo@sydney.edu.au;University of Sydney;Darcy Road;Westmead;NSW;2145;Australia;NONE;47323;melanoma;BRAF V600E;subcutaneous;none;18;Pre untreated;0,105518341;0;0;0,093814868;0;0;0,800666791
Patient;18;Pre untreated (replicate);GSM1220454;Patient 18 Pre untreated (replicate);Public on Feb 19 2014;Aug 30 2013;Feb 19 2014;RNA;1;Melanoma tumour;Homo sapiens;genotype: BRAF V600E;disease state: melanoma;location: subcutaneous;treatment: none;total RNA;RNA was extracted with Trizol reagent, followed by clean-up and DNase I treatment with QIAGEN RNeasy mini kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.;biotin;Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays;9606;Standard Illumina hybridization protocol;Standard Illumina scanning protocol;Patient 18 Pre untreated (replicate);The data were normalised using with cubic spline using the Illumina GenomeStudio v2011.1;GPL10558;Gulietta,,Pupo;gulietta.pupo@sydney.edu.au;University of Sydney;Darcy Road;Westmead;NSW;2145;Australia;NONE;47323;melanoma;BRAF V600E;subcutaneous;none;18;Pre untreated (replicate);0,106469774;0;0;0,097168348;0;0;0,796361878
Patient;18;Prog 1 Treated with dabrafenib;GSM1220455;Patient 18 Prog 1 Treated with dabrafenib;Public on Feb 19 2014;Aug 30 2013;Feb 19 2014;RNA;1;Melanoma tumour;Homo sapiens;genotype: BRAF V600E;disease state: melanoma;location: bowel;treatment: dabrafenib;total RNA;RNA was extracted with Trizol reagent, followed by clean-up and DNase I treatment with QIAGEN RNeasy mini kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.;biotin;Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays;9606;Standard Illumina hybridization protocol;Standard Illumina scanning protocol;Patient 18 Prog 1 Treated with dabrafenib;The data were normalised using with cubic spline using the Illumina GenomeStudio v2011.1;GPL10558;Gulietta,,Pupo;gulietta.pupo@sydney.edu.au;University of Sydney;Darcy Road;Westmead;NSW;2145;Australia;NONE;47323;melanoma;BRAF V600E;bowel;dabrafenib;18;Prog 1 Treated with dabrafenib;0,149691463;0,010723098;0,031770677;0,068195386;0,031909035;0,201252754;0,506457588
Patient;18;Prog 2 Treated with dabrafenib;GSM1220456;Patient 18 Prog 2 Treated with dabrafenib;Public on Feb 19 2014;Aug 30 2013;Feb 19 2014;RNA;1;Melanoma tumour;Homo sapiens;genotype: BRAF V600E;disease state: melanoma;location: subcutaneous;treatment: dabrafenib;total RNA;RNA was extracted with Trizol reagent, followed by clean-up and DNase I treatment with QIAGEN RNeasy mini kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.;biotin;Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays;9606;Standard Illumina hybridization protocol;Standard Illumina scanning protocol;Patient 18 Prog 2 Treated with dabrafenib;The data were normalised using with cubic spline using the Illumina GenomeStudio v2011.1;GPL10558;Gulietta,,Pupo;gulietta.pupo@sydney.edu.au;University of Sydney;Darcy Road;Westmead;NSW;2145;Australia;NONE;47323;melanoma;BRAF V600E;subcutaneous;dabrafenib;18;Prog 2 Treated with dabrafenib;0,150422756;0,076090912;0,033179732;0;0,007711356;0,167154997;0,565440246
Patient;21;Pre untreated;GSM1220457;Patient 21 Pre untreated;Public on Feb 19 2014;Aug 30 2013;Feb 19 2014;RNA;1;Melanoma tumour;Homo sapiens;genotype: BRAF V600E;disease state: melanoma;location: subcutaneous;treatment: none;total RNA;RNA was extracted with Trizol reagent, followed by clean-up and DNase I treatment with QIAGEN RNeasy mini kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.;biotin;Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays;9606;Standard Illumina hybridization protocol;Standard Illumina scanning protocol;Patient 21 Pre untreated;The data were normalised using with cubic spline using the Illumina GenomeStudio v2011.1;GPL10558;Gulietta,,Pupo;gulietta.pupo@sydney.edu.au;University of Sydney;Darcy Road;Westmead;NSW;2145;Australia;NONE;47323;melanoma;BRAF V600E;subcutaneous;none;21;Pre untreated;0,161554803;0,060677247;0,070573926;0;0,008113433;0,04432849;0,654752101
Patient;21;Prog Treated with dabrafenib;GSM1220458;Patient 21 Prog Treated with dabrafenib;Public on Feb 19 2014;Aug 30 2013;Feb 19 2014;RNA;1;Melanoma tumour;Homo sapiens;genotype: BRAF V600E;disease state: melanoma;location: brain;treatment: dabrafenib;total RNA;RNA was extracted with Trizol reagent, followed by clean-up and DNase I treatment with QIAGEN RNeasy mini kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.;biotin;Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays;9606;Standard Illumina hybridization protocol;Standard Illumina scanning protocol;Patient 21 Prog Treated with dabrafenib;The data were normalised using with cubic spline using the Illumina GenomeStudio v2011.1;GPL10558;Gulietta,,Pupo;gulietta.pupo@sydney.edu.au;University of Sydney;Darcy Road;Westmead;NSW;2145;Australia;NONE;47323;melanoma;BRAF V600E;brain;dabrafenib;21;Prog Treated with dabrafenib;0,125789669;0,050159378;0,080317669;0,011395608;0,012633212;0,12099846;0,598706003
Patient;23;Pre untreated;GSM1220459;Patient 23 Pre untreated;Public on Feb 19 2014;Aug 30 2013;Feb 19 2014;RNA;1;Melanoma tumour;Homo sapiens;genotype: BRAF V600E;disease state: melanoma;location: subcutaneous;treatment: none;total RNA;RNA was extracted with Trizol reagent, followed by clean-up and DNase I treatment with QIAGEN RNeasy mini kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.;biotin;Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays;9606;Standard Illumina hybridization protocol;Standard Illumina scanning protocol;Patient 23 Pre untreated;The data were normalised using with cubic spline using the Illumina GenomeStudio v2011.1;GPL10558;Gulietta,,Pupo;gulietta.pupo@sydney.edu.au;University of Sydney;Darcy Road;Westmead;NSW;2145;Australia;NONE;47323;melanoma;BRAF V600E;subcutaneous;none;23;Pre untreated;0,108088926;0,047561502;0,044626128;0,112377855;0,040593369;0,113047014;0,533705205
Patient;23;Prog Treated with vemurafenib;GSM1220460;Patient 23 Prog Treated with vemurafenib;Public on Feb 19 2014;Aug 30 2013;Feb 19 2014;RNA;1;Melanoma tumour;Homo sapiens;genotype: BRAF V600E;disease state: melanoma;location: subcutaneous;treatment: vemurafenib;total RNA;RNA was extracted with Trizol reagent, followed by clean-up and DNase I treatment with QIAGEN RNeasy mini kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.;biotin;Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays;9606;Standard Illumina hybridization protocol;Standard Illumina scanning protocol;Patient 23 Prog Treated with vemurafenib;The data were normalised using with cubic spline using the Illumina GenomeStudio v2011.1;GPL10558;Gulietta,,Pupo;gulietta.pupo@sydney.edu.au;University of Sydney;Darcy Road;Westmead;NSW;2145;Australia;NONE;47323;melanoma;BRAF V600E;subcutaneous;vemurafenib;23;Prog Treated with vemurafenib;0,166957481;0,091939254;0,038455166;0,096198482;0,039022667;0,017139003;0,550287947
Patient;24;Pre untreated;GSM1220461;Patient 24 Pre untreated;Public on Feb 19 2014;Aug 30 2013;Feb 19 2014;RNA;1;Melanoma tumour;Homo sapiens;genotype: BRAF V600E;disease state: melanoma;location: subcutaneous;treatment: none;total RNA;RNA was extracted with Trizol reagent, followed by clean-up and DNase I treatment with QIAGEN RNeasy mini kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.;biotin;Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays;9606;Standard Illumina hybridization protocol;Standard Illumina scanning protocol;Patient 24 Pre untreated;The data were normalised using with cubic spline using the Illumina GenomeStudio v2011.1;GPL10558;Gulietta,,Pupo;gulietta.pupo@sydney.edu.au;University of Sydney;Darcy Road;Westmead;NSW;2145;Australia;NONE;47323;melanoma;BRAF V600E;subcutaneous;none;24;Pre untreated;0,108907697;0,034092518;0,053102273;0;0;0,198636607;0,605260904
Patient;24;Pre untreated (replicate);GSM1220462;Patient 24 Pre untreated (replicate);Public on Feb 19 2014;Aug 30 2013;Feb 19 2014;RNA;1;Melanoma tumour;Homo sapiens;genotype: BRAF V600E;disease state: melanoma;location: subcutaneous;treatment: none;total RNA;RNA was extracted with Trizol reagent, followed by clean-up and DNase I treatment with QIAGEN RNeasy mini kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.;biotin;Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays;9606;Standard Illumina hybridization protocol;Standard Illumina scanning protocol;Patient 24 Pre untreated (replicate);The data were normalised using with cubic spline using the Illumina GenomeStudio v2011.1;GPL10558;Gulietta,,Pupo;gulietta.pupo@sydney.edu.au;University of Sydney;Darcy Road;Westmead;NSW;2145;Australia;NONE;47323;melanoma;BRAF V600E;subcutaneous;none;24;Pre untreated (replicate);0,115746032;0,030564111;0,042908731;0;0;0,224867671;0,585913455
Patient;24;Prog Treated with vemurafenib;GSM1220463;Patient 24 Prog Treated with vemurafenib;Public on Feb 19 2014;Aug 30 2013;Feb 19 2014;RNA;1;Melanoma tumour;Homo sapiens;genotype: BRAF V600E;disease state: melanoma;location: subcutaneous;treatment: vemurafenib;total RNA;RNA was extracted with Trizol reagent, followed by clean-up and DNase I treatment with QIAGEN RNeasy mini kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.;biotin;Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays;9606;Standard Illumina hybridization protocol;Standard Illumina scanning protocol;Patient 24 Prog Treated with vemurafenib;The data were normalised using with cubic spline using the Illumina GenomeStudio v2011.1;GPL10558;Gulietta,,Pupo;gulietta.pupo@sydney.edu.au;University of Sydney;Darcy Road;Westmead;NSW;2145;Australia;NONE;47323;melanoma;BRAF V600E;subcutaneous;vemurafenib;24;Prog Treated with vemurafenib;0,084160177;0,002959919;0,009931989;0;0;0,403240741;0,499707173
Patient;25;Pre untreated;GSM1220464;Patient 25 Pre untreated;Public on Feb 19 2014;Aug 30 2013;Feb 19 2014;RNA;1;Melanoma tumour;Homo sapiens;genotype: BRAF V600K;disease state: melanoma;location: lymph node;treatment: none;total RNA;RNA was extracted with Trizol reagent, followed by clean-up and DNase I treatment with QIAGEN RNeasy mini kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.;biotin;Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays;9606;Standard Illumina hybridization protocol;Standard Illumina scanning protocol;Patient 25 Pre untreated;The data were normalised using with cubic spline using the Illumina GenomeStudio v2011.1;GPL10558;Gulietta,,Pupo;gulietta.pupo@sydney.edu.au;University of Sydney;Darcy Road;Westmead;NSW;2145;Australia;NONE;47323;melanoma;BRAF V600K;lymph node;none;25;Pre untreated;0,070904293;0,043634578;0,058715542;0;0,000422498;0,281293031;0,545030059
Patient;25;Prog Treated with vemurafenib;GSM1220465;Patient 25 Prog Treated with vemurafenib;Public on Feb 19 2014;Aug 30 2013;Feb 19 2014;RNA;1;Melanoma tumour;Homo sapiens;genotype: BRAF V600K;disease state: melanoma;location: subcutaneous;treatment: vemurafenib;total RNA;RNA was extracted with Trizol reagent, followed by clean-up and DNase I treatment with QIAGEN RNeasy mini kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.;biotin;Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays;9606;Standard Illumina hybridization protocol;Standard Illumina scanning protocol;Patient 25 Prog Treated with vemurafenib;The data were normalised using with cubic spline using the Illumina GenomeStudio v2011.1;GPL10558;Gulietta,,Pupo;gulietta.pupo@sydney.edu.au;University of Sydney;Darcy Road;Westmead;NSW;2145;Australia;NONE;47323;melanoma;BRAF V600K;subcutaneous;vemurafenib;25;Prog Treated with vemurafenib;0,202402009;0;0;0,180551375;0,065825091;0;0,551221524
Patient;28;Pre untreated;GSM1220466;Patient 28 Pre untreated;Public on Feb 19 2014;Aug 30 2013;Feb 19 2014;RNA;1;Melanoma tumour;Homo sapiens;genotype: BRAF V600R;disease state: melanoma;location: subcutaneous;treatment: none;total RNA;RNA was extracted with Trizol reagent, followed by clean-up and DNase I treatment with QIAGEN RNeasy mini kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.;biotin;Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays;9606;Standard Illumina hybridization protocol;Standard Illumina scanning protocol;Patient 28 Pre untreated;The data were normalised using with cubic spline using the Illumina GenomeStudio v2011.1;GPL10558;Gulietta,,Pupo;gulietta.pupo@sydney.edu.au;University of Sydney;Darcy Road;Westmead;NSW;2145;Australia;NONE;47323;melanoma;BRAF V600R;subcutaneous;none;28;Pre untreated;0,045823681;0,057187057;0,046782299;0;0;0,316035884;0,53417108
Patient;28;Prog 1 Treated with vemurafenib;GSM1220467;Patient 28 Prog 1 Treated with vemurafenib;Public on Feb 19 2014;Aug 30 2013;Feb 19 2014;RNA;1;Melanoma tumour;Homo sapiens;genotype: BRAF V600R;disease state: melanoma;location: subcutaneous;treatment: vemurafenib;total RNA;RNA was extracted with Trizol reagent, followed by clean-up and DNase I treatment with QIAGEN RNeasy mini kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.;biotin;Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays;9606;Standard Illumina hybridization protocol;Standard Illumina scanning protocol;Patient 28 Prog 1 Treated with vemurafenib;The data were normalised using with cubic spline using the Illumina GenomeStudio v2011.1;GPL10558;Gulietta,,Pupo;gulietta.pupo@sydney.edu.au;University of Sydney;Darcy Road;Westmead;NSW;2145;Australia;NONE;47323;melanoma;BRAF V600R;subcutaneous;vemurafenib;28;Prog 1 Treated with vemurafenib;0,082953089;0,033503849;0,013721252;0,017556553;0;0,418047974;0,434217283
Patient;28;Prog 2 Treated with vemurafenib;GSM1220468;Patient 28 Prog 2 Treated with vemurafenib;Public on Feb 19 2014;Aug 30 2013;Feb 19 2014;RNA;1;Melanoma tumour;Homo sapiens;genotype: BRAF V600R;disease state: melanoma;location: subcutaneous;treatment: vemurafenib;total RNA;RNA was extracted with Trizol reagent, followed by clean-up and DNase I treatment with QIAGEN RNeasy mini kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.;biotin;Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays;9606;Standard Illumina hybridization protocol;Standard Illumina scanning protocol;Patient 28 Prog 2 Treated with vemurafenib;The data were normalised using with cubic spline using the Illumina GenomeStudio v2011.1;GPL10558;Gulietta,,Pupo;gulietta.pupo@sydney.edu.au;University of Sydney;Darcy Road;Westmead;NSW;2145;Australia;NONE;47323;melanoma;BRAF V600R;subcutaneous;vemurafenib;28;Prog 2 Treated with vemurafenib;0,025602052;0,050024781;0,035040166;0,050153837;0,015403428;0,335310031;0,488465705
Patient;28;Prog 3 Treated with vemurafenib;GSM1220469;Patient 28 Prog 3 Treated with vemurafenib;Public on Feb 19 2014;Aug 30 2013;Feb 19 2014;RNA;1;Melanoma tumour;Homo sapiens;genotype: BRAF V600R;disease state: melanoma;location: subcutaneous;treatment: vemurafenib;total RNA;RNA was extracted with Trizol reagent, followed by clean-up and DNase I treatment with QIAGEN RNeasy mini kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.;biotin;Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays;9606;Standard Illumina hybridization protocol;Standard Illumina scanning protocol;Patient 28 Prog 3 Treated with vemurafenib;The data were normalised using with cubic spline using the Illumina GenomeStudio v2011.1;GPL10558;Gulietta,,Pupo;gulietta.pupo@sydney.edu.au;University of Sydney;Darcy Road;Westmead;NSW;2145;Australia;NONE;47323;melanoma;BRAF V600R;subcutaneous;vemurafenib;28;Prog 3 Treated with vemurafenib;0,129136203;0,035366851;0,045393066;0,10104703;0;0,086012964;0,603043887
Patient;28;Prog 4 Treated with vemurafenib;GSM1220470;Patient 28 Prog 4 Treated with vemurafenib;Public on Feb 19 2014;Aug 30 2013;Feb 19 2014;RNA;1;Melanoma tumour;Homo sapiens;genotype: BRAF V600R;disease state: melanoma;location: subcutaneous;treatment: vemurafenib;total RNA;RNA was extracted with Trizol reagent, followed by clean-up and DNase I treatment with QIAGEN RNeasy mini kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.;biotin;Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays;9606;Standard Illumina hybridization protocol;Standard Illumina scanning protocol;Patient 28 Prog 4 Treated with vemurafenib;The data were normalised using with cubic spline using the Illumina GenomeStudio v2011.1;GPL10558;Gulietta,,Pupo;gulietta.pupo@sydney.edu.au;University of Sydney;Darcy Road;Westmead;NSW;2145;Australia;NONE;47323;melanoma;BRAF V600R;subcutaneous;vemurafenib;28;Prog 4 Treated with vemurafenib;0,037285508;0,06365193;0,034761262;0,007141274;0;0,260439773;0,596720254
Patient;30;Pre untreated;GSM1220471;Patient 30 Pre untreated;Public on Feb 19 2014;Aug 30 2013;Feb 19 2014;RNA;1;Melanoma tumour;Homo sapiens;genotype: BRAF V600E;disease state: melanoma;location: subcutaneous;treatment: none;total RNA;RNA was extracted with Trizol reagent, followed by clean-up and DNase I treatment with QIAGEN RNeasy mini kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.;biotin;Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays;9606;Standard Illumina hybridization protocol;Standard Illumina scanning protocol;Patient 30 Pre untreated;The data were normalised using with cubic spline using the Illumina GenomeStudio v2011.1;GPL10558;Gulietta,,Pupo;gulietta.pupo@sydney.edu.au;University of Sydney;Darcy Road;Westmead;NSW;2145;Australia;NONE;47323;melanoma;BRAF V600E;subcutaneous;none;30;Pre untreated;0,079148285;0,049869846;0,018176307;0;0,005184524;0,309186836;0,538434201
Patient;30;Prog Treated with vemurafenib;GSM1220472;Patient 30 Prog Treated with vemurafenib;Public on Feb 19 2014;Aug 30 2013;Feb 19 2014;RNA;1;Melanoma tumour;Homo sapiens;genotype: BRAF V600E;disease state: melanoma;location: lung;treatment: vemurafenib;total RNA;RNA was extracted with Trizol reagent, followed by clean-up and DNase I treatment with QIAGEN RNeasy mini kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.;biotin;Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays;9606;Standard Illumina hybridization protocol;Standard Illumina scanning protocol;Patient 30 Prog Treated with vemurafenib;The data were normalised using with cubic spline using the Illumina GenomeStudio v2011.1;GPL10558;Gulietta,,Pupo;gulietta.pupo@sydney.edu.au;University of Sydney;Darcy Road;Westmead;NSW;2145;Australia;NONE;47323;melanoma;BRAF V600E;lung;vemurafenib;30;Prog Treated with vemurafenib;0,198038836;0;0;0,081579436;0;0;0,720381728